For: | Cheung KS, Seto WK, Fung J, Mak LY, Lai CL, Yuen MF. Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis. World J Gastroenterol 2017; 23(44): 7863-7874 [PMID: 29209127 DOI: 10.3748/wjg.v23.i44.7863] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i44/7863.htm |
Number | Citing Articles |
1 |
Giovanni Marasco, Antonio Colecchia, Giovanni Silva, Benedetta Rossini, Leonardo Henry Eusebi, Federico Ravaioli, Elton Dajti, Luigina Vanessa Alemanni, Luigi Colecchia, Matteo Renzulli, Rita Golfieri, Davide Festi. Non-invasive tests for the prediction of primary hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(24): 3326-3343 doi: 10.3748/wjg.v26.i24.3326
|
2 |
Longqing Shi, Zhen Qu, Yue Yang, Yue Zhang, Donglin Sun, Min Tang. Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/8195512
|
3 |
Maren H. Harms, Gideon M. Hirschfield, Annarosa Floreani, Marlyn J. Mayo, Albert Parés, Alexander Liberman, Elizabeth Smoot Malecha, Richard Pencek, Leigh MacConell, Bettina E. Hansen. Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitis. JHEP Reports 2021; 3(1): 100191 doi: 10.1016/j.jhepr.2020.100191
|
4 |
Xiaowen Zhang, Ka-Shing Cheung, Lung-Yi Mak, Kathryn C B Tan, Annie W C Kung, Ian Chi-Kei Wong, Ching-Lung Cheung. Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis. The Journal of Clinical Endocrinology & Metabolism 2024; doi: 10.1210/clinem/dgae223
|
5 |
Dustin E. Bosch, Yoh Zen, Sarag A. Boukhar, Yongjun Liu, Lin Cheng, Matthew M. Yeh. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. Virchows Archiv 2021; 479(6): 1131 doi: 10.1007/s00428-021-03183-6
|
6 |
Ashnila Janmohamed, Palak J. Trivedi. Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC). Best Practice & Research Clinical Gastroenterology 2018; : 71 doi: 10.1016/j.bpg.2018.06.002
|
7 |
Jialiang Chen, Dongying Xue, Fangyuan Gao, Le Tao, Yuxin Li, Qun Zhang, Rui Wang, Le Sun, Xue Yang, Yao Liu, Bingbing Zhu, Shuaishuai Niu, Xianbo Wang. Influence factors and a predictive scoring model for measuring the biochemical response of primary biliary cholangitis to ursodeoxycholic acid treatment. European Journal of Gastroenterology & Hepatology 2018; 30(11): 1352 doi: 10.1097/MEG.0000000000001186
|
8 |
Kazuo Tarao, Akito Nozaki, Takaaki Ikeda, Akira Sato, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment. Cancer Medicine 2019; 8(3): 1054 doi: 10.1002/cam4.1998
|